ES Therapeutics Australia Pty Ltd
3 clinical trials · Sponsor
◉ Watch ES Therapeutics Australia Pty Ltd
| Record | Firm | Date |
|---|---|---|
| Efficacy, Safety, and Pharmacokinetics of ES-481 in Adult Patients With Essential Tremors (NCT05234762) | ES Therapeutics Australia Pty Ltd | 2021-11-21 |
| ES-481 for Uncontrolled Glioma-Associated Epilepsy and Assessment for Potential Anti-Tumorigenic Effect in Patients With Isocitrate Dehydrogenase 1 (IDH1) Mutant Tumors (NCT04737174) | ES Therapeutics Australia Pty Ltd | 2021-03-25 |
| Efficacy, Safety and Pharmacokinetics of ES-481 in Adult Patients With Drug Resistant Epilepsy (NCT04714996) | ES Therapeutics Australia Pty Ltd | 2020-10-30 |
Track ES Therapeutics Australia Pty Ltd automatically
Every clearance here is in the API, with alerts when new ones post.